IL-23 Antibodies in Psoriasis - a Non-Clinical Perspective

被引：2
|
作者：
Zhou, L. [1 ]
Wang, Y. [2 ]
Wan, Q. [1 ]
Perron, D. [1 ]
Zhu, R. [1 ]
Wang, L. [1 ]
Gauld, S. [2 ]
Veldman, T. [1 ]
机构：
[1] Abbvie Biores Ctr, Worcester, MA USA
[2] Abbvie, N Chicago, IL USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 09期
关键词：
D O I：
10.1016/j.jid.2019.07.396
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
394
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 50 条
  • [21] Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis
    Tonel, Giulia
    Conrad, Curdin
    Laggner, Ute
    Di Meglio, Paola
    Grys, Katarzyna
    McClanahan, Terrill K.
    Blumenschein, Wendy M.
    Qin, Jian-Zhong
    Xin, Hong
    Oldham, Elizabeth
    Kastelein, Robert
    Nickoloff, Brian J.
    Nestle, Frank O.
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (10): : 5688 - 5691
  • [22] New Biologics in Psoriasis: An Update on IL-23 and IL-17 Inhibitors
    Dong, Joanna
    Goldenberg, Gary
    [J]. CUTIS, 2017, 99 (02): : 123 - 127
  • [23] A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response
    Wu, David
    Hailer, Ashley A.
    Wang, Sijia
    Yuan, Michelle
    Chan, Jamie
    El Kurdi, Abdullah
    Han, David
    Ali, Hira
    D'Angio, Blaize
    Mayer, Aaron
    Rahim, Maha
    Kondo, Ayano
    Klufas, Daniel M.
    Kim, Esther A.
    Shain, A. Hunter
    Choi, Jaehyuk
    Bhutani, Tina
    Simpson, Gregory L.
    Grekin, Roy C.
    Ricardo-Gonzalez, Roberto R.
    Purdom, Elizabeth
    North, Jeffrey P.
    Cheng, Jeffrey B.
    Cho, Raymond J.
    [J]. SCIENCE IMMUNOLOGY, 2024, 9 (91)
  • [24] IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis
    Witte, Ellen
    Kokolakis, Georgios
    Witte, Katrin
    Philipp, Sandra
    Doecke, Wolf-Dietrich
    Babel, Nina
    Wittig, Bianca M.
    Warszawska, Katarzyna
    Kurek, Agata
    Erdmann-Keding, Magdalena
    Kunz, Stefanie
    Asadullah, Khusru
    Kadin, Marshall E.
    Volk, Hans-Dieter
    Sterry, Wolfram
    Wolk, Kerstin
    Sabat, Robert
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (11) : 2757 - 2767
  • [25] How to choose between IL-17 inhibitors and IL-23 inhibitors for psoriasis
    Amin, Mina
    Lee, Erica B.
    Wu, Jashin J.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (04) : 374 - 375
  • [26] Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis
    Alunno, Alessia
    Carubbi, Francesco
    Cafaro, Giacomo
    Pucci, Giacomo
    Battista, Francesca
    Bartoloni, Elena
    Giacomelli, Roberto
    Schillaci, Giuseppe
    Gerli, Roberto
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1727 - 1737
  • [27] Dysregulated production of IL-23 by Langerhans Cells from psoriasis patients
    Sweeney, C. M.
    Adamzik, K.
    Tobin, A.
    Kirby, B.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S28 - S28
  • [28] The role of IL-23 and the use IL-23 inhibitors in psoriatic arthritis
    Fragoulis, George E.
    Siebert, Stefan
    [J]. MUSCULOSKELETAL CARE, 2022, 20 : S12 - S21
  • [29] IL-36y is a strong inducer of IL-23 production and angiogenesis in psoriasis
    Bridgewood, C.
    Fearnley, G.
    Keszegpal, A.
    Laws, P.
    Ponnambalam, S.
    Graham, A.
    Stacey, M.
    Wittmann, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S246 - S246
  • [30] Selective Il-23 Inhibitors: The New Kids on the Block in the Treatment of Psoriasis
    Torres, T.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (08): : 674 - 676
12345